InsiderTrades

Form 4 for EXC Exelon

Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-19 · accession 0001062993-21-011390 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-22 2021-11-19 EXC Crane Christopher M. Pres, CEO S - Sale+OE $53.49 -285.0K 489.3K -37% -$15.24M
D 2021-11-22 2021-11-19 EXC Crane Christopher M. Pres, CEO M - OptEx $39.21 +285.0K 774.3K +58% +$11.17M
D 2021-11-22 2021-11-19 EXC Crane Christopher M. Pres, CEO M - OptEx — -285.0K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-19 S D 285,000 $53.49 489,323 D — — (F2) Shares were sold in multiple lots with prices ranging from $53.22 to $53.79 inclusive. Mr Crane undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at at each separate price within the range provided above.
2 Common Common Stock 2021-11-19 M A 285,000 $39.21 774,323 D — — (F3) Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1.
3 Derivative NQ Stock Option (right to buy) 04/02/2012 2021-11-19 M D 285,000 — 0 D $39.21 · — to — 285,000 Common Stock (F3) Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1.